Cytology of canine malignant histiocytosis

Diane E. Brown1, Mary Anna Thrall, David M. Getzy

  • 1Department of Pathology, College of Veterinary Medicine and Biomedical Sciences, Colorado Sate University, Fort Collins, CO 80523.

Insights

Lysozyme immunohistochemistry aids in diagnosing canine malignant histiocytosis. This diagnostic tool identifies neoplastic cells in cytology and tissue samples, crucial for this aggressive cancer.

Area of Science:

  • Veterinary Pathology
  • Canine Oncology
  • Cytopathology

Background:

  • Malignant histiocytosis is an aggressive neoplastic disease in dogs.
  • Accurate diagnosis is essential for prognosis and treatment.

Purpose of the Study:

  • To describe the cytologic features of malignant histiocytosis in dogs.
  • To evaluate the utility of lysozyme immunohistochemistry for diagnosis.

Main Methods:

  • Review of seven canine cases with malignant histiocytosis.
  • Analysis of bone marrow, tissue, and abdominal fluid cytology.
  • Histopathology, hematology, serum biochemistry, and immunohistochemistry.

Main Results:

  • Neoplastic cells showed positive immunoreactivity to lysozyme.
  • Cytologic findings included pleomorphic mononuclear cells, anisocytosis, anisokaryosis, and prominent nucleoli.
  • Hematologic abnormalities included anemia and thrombocytopenia; hypercalcemia was also observed.

Conclusions:

  • Lysozyme immunohistochemistry is a reliable method for diagnosing canine malignant histiocytosis.
  • Cytologic features are characteristic and aid in diagnosis.
  • Early and accurate diagnosis is critical for affected dogs.

Related Concept Videos